title: Evaluation of coagulation in pediatric bone marrow transplantation patients.
abstract: A hypercoagulable state is frequently described in adult patients undergoing bone marrow transplantation (BMT). In this study, the coagulation profile of 29 children was prospectively investigated in the pre- and post-transplant period. A significant rise in the activated partial thromboplastin time (aPTT) values was detected on days 7 and 14 after transplantation. Moreover, an increase in the d-dimer level was also notable, regardless of the clinical condition of the patients. The other coagulation parameters investigated (i.e. protein S, protein C, anti-thrombin III, factor VIII, von Willebrand factor, and prothrombin time) remained essentially unchanged. However, hyper-fibrinogenemia was observed in all patients with chronic myeloid leukemia (CML) (n=5) before and after transplantation. In summary, in the present study pediatric bone marrow transplantation patients did not show a hyper-coagulable state after marrow infusion. However, a significant rise in PTT and d-dimer values were noted.
authors.affiliation: ABC Child Health Center, Gaziosmanpaşa, Ankara, Turkey. m-tuncer@br.net.tr
authors.forename: I
authors.initials: I
authors.lastname: Yenicesu
authors.forename: D
authors.initials: D
authors.lastname: Uçkan
authors.forename: M
authors.initials: M
authors.lastname: Cetin
authors.forename: A M
authors.initials: AM
authors.lastname: Tuncer
authors.forename: I
authors.initials: I
authors.lastname: Tezcan
authors.forename: A
authors.initials: A
authors.lastname: Gürgey
mesh_terms: D000293:Adolescent; D001777:Blood Coagulation; D016026:Bone Marrow Transplantation / Q000502:physiology*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D006801:Humans; D007223:Infant; D008297:Male; D010314:Partial Thromboplastin Time; D011446:Prospective Studies; D011486:Protein C / Q000032:analysis; D017293:Protein S / Q000032:analysis
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D011486:Protein C; D017293:Protein S; C036309:fibrin fragment D